← Leaderboards
Brian Jesse Debosch
Washington University
$7,536,271
Attributed
$7,536,271
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,536,271 · 8
By mechanism
R01$6,221,036 · 3
P30$501,547 · 3
R21$432,438 · 1
R56$381,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Marshall Alan Permutt$16,076,220
- Timothy J Eberlein$71,591,509
- Michael Simon Avidan$9,181,554
- Eric J Lenze$35,080,787
- Gary D Stormo$11,289,482
Others in their field
Other Emerging Leaders on “Metabolism”
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Rainer Lohmann · University Of Rhode Island$14,400,221
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
MetabolismSignal TransductionNon-Alcoholic Fatty Liver DiseaseHepatocytePathway InteractionsFasting GlucoseFastingLiverFatty LiverHepaticAttenuatedResponseGlucose TransportAutophagocytosisDiabetes MellitusTherapeutic EffectMouse ModelNext GenerationCardiovascular SystemInsulin ResistancePreventMimeticsDisaccharidesTrehalose
Grant awards (24)
Leveraging arginase biology against metabolic disease$440,154
R01 · FY2025 · DK · contact PI
Enrichment Program$15,442
P30 · FY2025 · DK · contact PI
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response$612,000
R01 · FY2024 · HL · contact PI
Leveraging arginase biology against metabolic disease$416,258
R01 · FY2024 · DK · contact PI
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism$389,892
R01 · FY2024 · DK · contact PI
Pilot & Feasibility Program$205,217
P30 · FY2024 · DK · contact PI
Enrichment Program$30,771
P30 · FY2024 · DK · contact PI
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response$5,050
R01 · FY2024 · HL · contact PI
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism$1
R01 · FY2024 · DK · contact PI
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response$626,492
R01 · FY2023 · HL · contact PI
Leveraging arginase biology against metabolic disease$436,856
R01 · FY2023 · DK · contact PI
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism$404,028
R01 · FY2023 · DK · contact PI
Pilot & Feasibility Program$203,791
P30 · FY2023 · DK · contact PI
Enrichment Program$15,442
P30 · FY2023 · DK · contact PI
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response$629,642
R01 · FY2022 · HL · contact PI
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism$440,186
R01 · FY2022 · DK · contact PI
Enrichment Program$15,442
P30 · FY2022 · DK · contact PI
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response$678,171
R01 · FY2021 · HL · contact PI
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism$448,239
R01 · FY2021 · DK · contact PI
Enrichment Program$15,442
P30 · FY2021 · DK · contact PI
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response$694,067
R01 · FY2020 · HL · contact PI
Biological Effects and Mechanistic Actions of the Natural Disaccharide and Dietary Supplement, Trehalose.$196,875
R21 · FY2020 · AT · contact PI
Biological Effects and Mechanistic Actions of the Natural Disaccharide and Dietary Supplement, Trehalose.$235,563
R21 · FY2019 · AT · contact PI
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism$381,250
R56 · FY2018 · DK · contact PI